Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Johannes Fredebohm
Observed name:
J. Fredebohm
Institution:
Sysmex (Germany)
Observed institutions:
German Cancer Research Center,
Sysmex (Germany),
University of Otago
OpenAlex ID:
A5030349802
Performance of Streck cfDNA Blood Collection Tubes for Liquid Biopsy Testing
2016
·
Inga Medina Diaz
, Annette Nocon
, et al.
·
PLoS ONE
·
201
PDF
A mammosphere formation RNAi screen reveals that ATG4A promotes a breast cancer stem-like phenotype
2013
·
Jonas Wolf
, Dyah Laksmi Dewi
, et al.
·
Breast Cancer Research
·
140
PDF
Detection of TP53 and PIK3CA Mutations in Circulating Tumor DNA Using Next-Generation Sequencing in the Screening Process for Early Breast Cancer Diagnosis
2019
·
Begona Jimenez Rodriguez
, Gema Diaz Córdoba
, et al.
·
Journal of Clinical Medicine
·
60
Pre-Analytical Evaluation of Streck Cell-Free DNA Blood Collection Tubes for Liquid Profiling in Oncology
2023
·
Inga Medina Diaz
, Annette Nocon
, et al.
·
Diagnostics
·
52
PDF
Methylisoindigo preferentially kills cancer stem cells by interfering cell metabolism via inhibition of LKB1 and activation of AMPK in PDACs
2016
·
Xinlai Cheng
, Jee Young Kim
, et al.
·
Molecular Oncology
·
51
PDF
Establishment and Characterization of a Highly Tumourigenic and Cancer Stem Cell Enriched Pancreatic Cancer Cell Line as a Well Defined Model System
2012
·
Johannes Fredebohm
, Michael Boettcher
, et al.
·
PLoS ONE
·
43
PDF
Bioinformatic, structural, and functional analyses support release factor-like MTRF1 as a protein able to decode nonstandard stop codons beginning with adenine in vertebrate mitochondria
2010
·
David J. Young
, Christina D. Edgar
, et al.
·
RNA
·
41
PDF
The deubiquitinating enzyme USP5 promotes pancreatic cancer via modulating cell cycle regulators
2017
·
Brajesh P. Kaistha
, Anja Krattenmacher
, et al.
·
Oncotarget
·
37
Depletion of RAD17 sensitizes pancreatic cancer cells to gemcitabine
2013
·
Johannes Fredebohm
, Jonas Wolf
, et al.
·
Journal of Cell Science
·
30
Next-generation sequencing (NGS) profiling of matched tumor and circulating tumor DNA (ctDNA) in head and neck squamous cell carcinoma (HNSCC)
2023
·
Panagiota Economopoulou
, Aris Spathis
, et al.
·
Oral Oncology
·
26
High throughput synthetic lethality screen reveals a tumorigenic role of adenylate cyclase in fumarate hydratase-deficient cancer cells
2014
·
Michael Boettcher
, Andrew Lawson
, et al.
·
BMC Genomics
·
22
PDF
Detection and Quantification of KIT Mutations in ctDNA by Plasma Safe-SeqS
2016
·
Johannes Fredebohm
, Daniel H. Mehnert
, et al.
·
Advances in experimental medicine and biology
·
21
Clearance of ctDNA in triple-negative and HER2-positive breast cancer patients during neoadjuvant treatment is correlated with pathologic complete response
2022
·
Nikaoly Ciriaco
, Esther Zamora
, et al.
·
Therapeutic Advances in Medical Oncology
·
18
Prospective study evaluating dynamic changes of cell-free HPV DNA in locoregional viral-associated oropharyngeal cancer treated with induction chemotherapy and response-adaptive treatment
2022
·
Ari J. Rosenberg
, Evgeny Izumchenko
, et al.
·
BMC Cancer
·
17
PDF
Decoding pooled RNAi screens by means of barcode tiling arrays
2010
·
Michael Boettcher
, Johannes Fredebohm
, et al.
·
BMC Genomics
·
13
PDF
Broad spectrum of regorafenib activity on mutant KIT and absence of clonal selection in gastrointestinal stromal tumor (GIST): correlative analysis from the GRID trial
2022
·
Michael Jeffers
, Christian Kappeler
, et al.
·
Gastric Cancer
·
11
PDF
Analytical and clinical performance validation of HPV-SEQ, a novel NGS-based liquid biopsy platform for detection and quantification of human papilloma virus circulating tumor DNA
2025
·
Samaneh Eickelschulte
, Anna Starus
, et al.
·
Oral Oncology
·
9
Ultra-sensitive detection and quantification of HPV DNA in the plasma of patients with oropharyngeal squamous cell carcinoma (OPSCC) enrolled in the OPTIMA 2 treatment de-escalation trial.
2021
·
Hillary Sloane
, Evgeny Izumchenko
, et al.
·
Journal of Clinical Oncology
·
6
Abstract A019: Analytical and clinical validation of HPV-SEQ, an NGS-based liquid biopsy platform for detection and quantification of human papilloma virus circulating tumor DNA
2024
·
Samaneh Eickelschulte
, Anna Starus
, et al.
·
Clinical Cancer Research
·
3
Monitoring ctDNA RAS Mutational Status in Metastatic Colorectal Cancer: A Trial Protocol of RAS-trace and RAS-trace-2 Studies
2024
·
Kozo Kataoka
, Takeshi Yamada
, et al.
·
Journal of the Anus Rectum and Colon
·
3
PDF
Abstract LB053: Clinical evaluation of NGS-based liquid biopsy genotyping in non-small cell lung cancer (NSCLC) patients
2021
·
Hillary Sloane
, Priya Sathyanarayan
, et al.
·
Cancer Research
·
2
Ultrasensitive Measurable Residual Disease (MRD) Detection in Acute Myeloid Leukemia (AML) Using a Targeted Next Generation Sequencing (NGS) Panel
2020
·
Lara Duchstein
, Hillary S Sloane
, et al.
·
Blood
·
2
Plasma sequencing of ctDNA in early stage breast cancer as part of the screening process.
2018
·
Begona Jimenez Rodriguez
, Gema Diaz Córdoba
, et al.
·
Journal of Clinical Oncology
·
2
Evaluation of Cell-Free HPV DNA in Patients With HPV-Associated Oropharyngeal Cancer Treated With Induction Chemotherapy and Response-Adaptive Therapy
2022
·
A.J. Rosenberg
, H. Sloane
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
1
Synthetic lethality screen identifies SMC2 as new target gene in pancreatic cancer
2014
·
Anja Krattenmacher
, Johannes Fredebohm
, et al.
·
Pancreatology
·
1
Show more works
View as search
Works count:
27
Citation count:
812
H-index:
14
I10-index:
16
Year
Topic
Type